A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Peer Review reports

Original Submission
17 Jun 2017	Submitted	Original manuscript
22 Jun 2017	Author responded	Author comments - Tim R Cressey
Resubmission - Version 2
22 Jun 2017	Submitted	Manuscript version 2
3 Jul 2017	Author responded	Author comments - Tim R Cressey
Resubmission - Version 3
3 Jul 2017	Submitted	Manuscript version 3
Publishing
4 Jul 2017	Editorially accepted
14 Jul 2017	Article published	10.1186/s12879-017-2593-4

Back to article page